IBS 2024 is Here! Are you attending the 2024 International Bordetella Symposium today? Let’s connect and make the most of this event!
The BioNet team will be actively participating over the next few days, ready to engage in impactful discussions and share cutting-edge ideas on pertussis vaccine development.
Please contact info@bionet.one.
We are thrilled to announce that on 27th June, we will present our groundbreaking new data in the Virtual Poster Session II from 18:30-19:30 CEST. Dr. Bahaa Abu-Raya will share insights on “Avidity of anti-PT IgG antibodies in mothers and their infants following vaccination with genetically-detoxified PT-containing vaccines in pregnancy: Analysis of a phase 2 randomized controlled trial”.
In addition, on 28th June, 13:00 CEST, BioNet will take part in the Vaccine Industry Roundtable, led by our Development Director, Mr. Mario Contorni. The focus will be on “Interactions between Basic Science and the Vaccine Industry.”
Join us for these insightful sessions, and let’s connect and collaborate at IBS 2024! See you there!
